Darvon and Darvocet (and their generics) have been used as Migraine rescue medications and for treating some other headache disorders.
Now, all medications containing propoxyphene have been pulled from the market following FDA studies of safety risks. Given that these medications have been on the market for more than 50 years, and that the study upon which this decision was made had only 18 participants, this is a very controversial decision.
Karen Lee Richards has written about this subject on our sister site, ChronicPainConnection.com. For more information, see her post, _FDA Pulls Darvon and Darvocet from the Market _.
Get the latest Migraine and headache news, informational articles, tips for living well, and more in my free weekly newsletter. To subscribe, CLICK HERE.
Teri Robert is a leading patient educator and advocate and the author of Living Well with Migraine Disease and Headaches. A co-founder of the Alliance for Headache Disorders Advocacy and the American Headache and Migraine Association, she received the National Headache Foundation’s Patient Partners Award and a Distinguished Service Award from the American Headache Society. Teri can be found on her website, and blog, Facebook, Twitter, StumbleUpon, Pinterest, LinkedIn, and Google+.